Works in Cancer Biology & Therapy, 2013, Vol 14, Issue 10

Results: 19

Investing in biomedical research is important.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 869, doi. 10.4161/cbt.26551

By:

El-deiry, Wafik S.

Publication type:

Article

Ceramide in the prostate.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 881, doi. 10.4161/cbt.26212

By:

Dent, Paul

Publication type:

Article

Multi-kinase modulation for colon cancer therapy.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 877, doi. 10.4161/cbt.26176

By:

Dent, Paul

Publication type:

Article

Non-canonical p53 signaling to promote invasion.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 879, doi. 10.4161/cbt.26174

By:

Dent, Paul

Publication type:

Article

Janus-faced Kupffer cells in tumor metastasis.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 875, doi. 10.4161/cbt.26161

By:

Dent, Paul

Publication type:

Article

PARP inhibitors are not all equal.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 873, doi. 10.4161/cbt.26160

By:

Dent, Paul

Publication type:

Article

Arsenic in leukemia.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 871, doi. 10.4161/cbt.26159

By:

Dent, Paul

Publication type:

Article

Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ ERBB2 therapy.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 982, doi. 10.4161/cbt.26234

By:

Cruickshanks, Nichola;
Hamed, Hossein A.;
Booth, Laurence;
Tavallai, Seyedmehrad;
Syed, Jahangir;
Sajithlal, Gangadharan B.;
Grant, Steven;
Poklepovic, Andrew;
Dent, Paul

Publication type:

Article

p19INK4d mRNA and protein expression as new prognostic factors in ovarian cancer patients.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 973, doi. 10.4161/cbt.25966

By:

Felisiak-Golabek, Anna;
Dansonka-Mieszkowska, Agnieszka;
Rzepecka, Iwona K.;
Szafron, Lukasz;
Kwiatkowska, Ewa;
Konopka, Bozena;
Podgorska, Agnieszka;
Rembiszewska, Alina;
Kupryjanczyk, Jolanta

Publication type:

Article

Prevalence of PIK3CA mutations and the SNP rs17849079 in Arab breast cancer patients.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 888, doi. 10.4161/cbt.25945

By:

Karakas, Bedri;
Colak, Dilek;
Kaya, Namik;
Ghebeh, Hazem;
Al-Qasem, Abeer;
Hendrayani, Fawziah;
Toulimat, Mohamed;
Al-Tweigeri, Taher;
Ben Ho Park;
Aboussekhra, Abdelilah

Publication type:

Article

In human retinoblastoma Y79 cells okadaic acid-parthenolide co-treatment induces synergistic apoptotic effects, with PTEN as a key player.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 922, doi. 10.4161/cbt.25944

By:

Di Fiore, Riccardo;
Drago-Ferrante, Rosa;
D'Anneo, Antonella;
Augello, Giuseppa;
Carlisi, Daniela;
De Blasio, Anna;
Giuliano, Michela;
Tesoriere, Giovanni;
Vento, Renza

Publication type:

Article

Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 962, doi. 10.4161/cbt.25943

By:

Mukhopadhyay, Archana;
Tabanor, Kayann;
Chaguturu, Rathnam;
Aldrich, Jane V.

Publication type:

Article

Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 883, doi. 10.4161/cbt.25942

By:

Zaorsky, Nicholas G.;
Yunguang Sun;
Zixuan Wang;
Palmer, Joshua;
Fortina, Paolo M.;
Solomides, Charalambos;
Werner-Wasik, Maria;
Dicker, Adam P.;
Axelrod, Rita;
Campling, Barbara;
Evans III, Nathaniel;
Cowan, Scott;
Bo Lu

Publication type:

Article

A model of sensitivity and resistance to histone deacetylase inhibitors in diffuse large B cell lymphoma.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 949, doi. 10.4161/cbt.25941

By:

Tula-Sanchez, Ana A.;
Havas, Aaron P.;
Alonge, Peter J.;
Klein, Mary E.;
Doctor, Samantha R.;
Pinkston, William;
Glinsmann-Gibson, Betty J.;
Rimsza, Lisa M.;
Smith, Catharine L.

Publication type:

Article

Endoglin is necessary for angiogenesis in human ovarian carcinoma-derived primary endothelial cells.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 937, doi. 10.4161/cbt.25940

By:

Yan Xu;
Dan Wang;
Li-Mei Zhao;
Xi-Long Zhao;
Jun-Jie Shen;
Yao Xie;
Li-Li Cao;
Zhen-Bo Chen;
Yan-Mei Luo;
Bi-Hui Bao;
Zhi-Qing Liang

Publication type:

Article

MK-2206, an Akt inhibitor, enhances carboplatinum/paclitaxel efficacy in gastric cancer cell lines.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 932, doi. 10.4161/cbt.25939

By:

Almhanna, Khaldoun;
Cubitt, Christopher L.;
Zhang, Shumin;
Kazim, Sabiha;
Husain, Kazim;
Sullivan, Dan;
Sebti, Said;
Malafa, Mokenge

Publication type:

Article

Numbers and cytotoxicities of CD3+CD56+ T lymphocytes in peripheral blood of patients with acute myeloid leukemia and acute lymphocytic leukemia.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 916, doi. 10.4161/cbt.25938

By:

Wenjian Guo;
Chao Xing;
Aishu Dong;
Xiaoji Lin;
Ying Lin;
Baoling Zhu;
Muqing He;
Rongxing Yao

Publication type:

Article

Galectin-3 inhibition sensitizes human renal cell carcinoma cells to arsenic trioxide treatment.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 897, doi. 10.4161/cbt.25937

By:

Yangyang Xu;
Xin Gu;
Mancheng Gong;
Guiying Guo;
Kaiyu Han;
Ruihua An

Publication type:

Article

Novel antioxidants are not toxic to normal tissues but effectively kill cancer cells.

Published in:

Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 907, doi. 10.4161/cbt.25935

By:

Kovalchuk, Anna;
Aladedunye, Felix;
Rodriguez-Juarez, Rocio;
Dongping Li;
Thomas, James;
Kovalchuk, Olga;
Przybylski, Roman

Publication type:

Article

Works in Cancer Biology & Therapy, 2013, Vol 14, Issue 10

Investing in biomedical research is important.

Ceramide in the prostate.

Multi-kinase modulation for colon cancer therapy.

Non-canonical p53 signaling to promote invasion.

Janus-faced Kupffer cells in tumor metastasis.

PARP inhibitors are not all equal.

Arsenic in leukemia.

Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ ERBB2 therapy.

p19<sup>INK4d</sup> mRNA and protein expression as new prognostic factors in ovarian cancer patients.

Prevalence of PIK3CA mutations and the SNP rs17849079 in Arab breast cancer patients.

In human retinoblastoma Y79 cells okadaic acid-parthenolide co-treatment induces synergistic apoptotic effects, with PTEN as a key player.

Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment.

Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab.

A model of sensitivity and resistance to histone deacetylase inhibitors in diffuse large B cell lymphoma.

Endoglin is necessary for angiogenesis in human ovarian carcinoma-derived primary endothelial cells.

MK-2206, an Akt inhibitor, enhances carboplatinum/paclitaxel efficacy in gastric cancer cell lines.

Numbers and cytotoxicities of CD3<sup>+</sup>CD56<sup>+</sup> T lymphocytes in peripheral blood of patients with acute myeloid leukemia and acute lymphocytic leukemia.

Galectin-3 inhibition sensitizes human renal cell carcinoma cells to arsenic trioxide treatment.

Novel antioxidants are not toxic to normal tissues but effectively kill cancer cells.